摘要
目的:优化静脉用药流程,促进用药安全。方法:运用失效模式与效应分析(FMEA)方法评估住院患者静脉用药流程潜在的风险因素,并结合用药流程探讨可能造成错误的原因,提出改善住院患者用药安全的可行性方案,并持续追踪改善成效。结果:在住院患者静脉用药流程中找到40项容易导致用药错误的高风险因素,并对高风险流程进行优化改造。改造后流程得到简化,用药错误风险较前明显降低。结论:FMEA作为一种风险管理工具,能使药品管理者前瞻性地发现住院患者在执行静脉用药流程中潜在的漏洞与风险,从而降低风险,防患于未然。
OBJECTIVE： To optimize the procedure of inlxavenous medication and improve medication safety. METHODS： Us- ing Failure Mode and Effects Analysis （FMEA）, the potential risk factors for intravenous medication process in the inpatients were evaluated, and the reasons for medication errors were investigated according to medication process. The possible programs to im- prove the safety of drug use were put forward, and the effects were followed continuously. RESULTS： 40 high-risk factors had been found in the process of intravenous medication. Then we reformed high-risk procedure. After that, the process was stream- lined, and the risk of medication errors reduced significantly. CONCLUSIONS： The results show that FMEA, as a risk manage- ment tool, can make the medication managers discover potential loopholes and risks in intravenous medication process of inpatient prospectively and adopt pertinent measures to reduce risks.
出处
《中国药房》
CAS
CSCD
2014年第10期938-941,共4页
China Pharmacy
关键词
失效模式与效应分析
静脉用药
风险管理
流程改造
Failure Mode and Effects Analysis
Intravenous medication
Risk management
Improvement process
